Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients

Purpose Data exploring optimal sequencing of anthracyclines and taxanes as neoadjuvant chemotherapy (NACT) for breast cancer are limited and inconsistent. The objective of this study was to assess the real-world impact of sequence order on pathologic complete response (pCR) and clinical outcomes fro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2021-05, Vol.187 (1), p.167-176
Hauptverfasser:	Tesch, M. E., Chia, S. K., Simmons, C. E., LeVasseur, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Anthracycline Anthracyclines Breast cancer Cancer Cancer patients Cancer research Care and treatment Chemotherapy Clinical outcomes Clinical Trial ErbB-2 protein Lumpectomy Medicine Medicine & Public Health Oncology Patients Surgery Survival Taxanes Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!